Current status of liposomal porphyrinoid photosensitizers
ORCiD
Nejat Düzgüneş: 0000-0001-6159-1391
Department
Biomedical Sciences
Document Type
Article
Publication Title
Drug Discovery Today
ISSN
1359-6446
Volume
18
Issue
15-16
DOI
10.1016/j.drudis.2013.04.003
First Page
776
Last Page
784
Publication Date
8-1-2013
Abstract
The complete eradication of various targets, such as infectious agents or cancer cells, while leaving healthy host cells untouched, is still a great challenge faced in the field of medicine. Photodynamic therapy (PDT) seems to be a promising approach for anticancer treatment, as well as to combat various dermatologic and ophthalmic diseases and microbial infections. The application of liposomes as delivery systems for porphyrinoids has helped overcome many drawbacks of conventional photosensitizers and facilitated the development of novel effective photosensitizers that can be encapsulated in liposomes. The development, preclinical studies and future directions for liposomal delivery of conventional and novel photosensitizers are reviewed. © 2013 Elsevier Ltd. All rights reserved.
Recommended Citation
Skupin-Mrugalska, P.,
Piskorz, J.,
Goslinski, T.,
Mielcarek, J.,
Konopka, K.,
&
Düzgüneş, N.
(2013).
Current status of liposomal porphyrinoid photosensitizers.
Drug Discovery Today, 18(15-16), 776–784.
DOI: 10.1016/j.drudis.2013.04.003
https://scholarlycommons.pacific.edu/dugoni-facarticles/614
